226 related articles for article (PubMed ID: 21543290)
1. Etanercept in the treatment of psoriasis and psoriatic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients.
Zanni M; Missale G; Santilli D; Di Nuzzo S
Eur J Dermatol; 2011; 21(4):564-7. PubMed ID: 21543290
[TBL] [Abstract][Full Text] [Related]
2. Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection.
Rokhsar C; Rabhan N; Cohen SR
J Am Acad Dermatol; 2006 Feb; 54(2):361-2. PubMed ID: 16443079
[No Abstract] [Full Text] [Related]
3. Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases.
Magliocco MA; Gottlieb AB
J Am Acad Dermatol; 2004 Oct; 51(4):580-4. PubMed ID: 15389194
[TBL] [Abstract][Full Text] [Related]
4. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
[TBL] [Abstract][Full Text] [Related]
5. Etanercept therapy in patients with psoriasis and concomitant HCV infection.
Garavaglia MC; Altomare G
Int J Immunopathol Pharmacol; 2010; 23(3):965-9. PubMed ID: 20943071
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept).
Cecchi R; Bartoli L
Dermatol Online J; 2006 Dec; 12(7):4. PubMed ID: 17459290
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
Mazzotta A; Esposito M; Costanzo A; Chimenti S
Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
[TBL] [Abstract][Full Text] [Related]
8. Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study.
de Vlam K; Lories RJ
Rheumatology (Oxford); 2006 Mar; 45(3):321-4. PubMed ID: 16234275
[TBL] [Abstract][Full Text] [Related]
9. [Clinical experience with etanercept in the treatment of psoriasis].
Martín B; Sánchez-Carazo JL; Pérez-Ferriols A; Laguna C; Oliver V; Alegre V
Actas Dermosifiliogr; 2008 Sep; 99(7):540-5. PubMed ID: 18682167
[TBL] [Abstract][Full Text] [Related]
10. Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection.
Linardaki G; Katsarou O; Ioannidou P; Karafoulidou A; Boki K
J Rheumatol; 2007 Jun; 34(6):1353-5. PubMed ID: 17552060
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients.
Prignano F; Ricceri F; Pescitelli L; Zanieri F; Lotti T
Br J Dermatol; 2011 Mar; 164(3):645-7. PubMed ID: 21375517
[TBL] [Abstract][Full Text] [Related]
12. Etanercept therapy in patients with autoimmunity and hepatitis C.
Khanna M; Shirodkar MA; Gottlieb AB
J Dermatolog Treat; 2003 Dec; 14(4):229-32. PubMed ID: 14660270
[TBL] [Abstract][Full Text] [Related]
13. Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data.
Paradisi A; Caldarola G; Capizzi R; Siciliano M; Annichiarico E; Vecchio FM; Amerio PL; De Simone C
J Am Acad Dermatol; 2010 Jun; 62(6):1067-9. PubMed ID: 20466184
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of etanercept in patients with psoriasis and hepatitis C.
Ventura F; Gomes J; Duarte Mda L; Fernandes JC; Brito C
Eur J Dermatol; 2010; 20(6):808-9. PubMed ID: 20923749
[No Abstract] [Full Text] [Related]
15. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
Paul C; Solignac M
Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
[No Abstract] [Full Text] [Related]
16. Etanercept for the treatment of psoriasis: combination therapy with other modalities.
Strober BE; Clarke S
J Drugs Dermatol; 2004; 3(3):270-2. PubMed ID: 15176161
[TBL] [Abstract][Full Text] [Related]
17. Two years of experience with etanercept in recalcitrant psoriasis.
Ahmad K; Rogers S
Br J Dermatol; 2007 May; 156(5):1010-4. PubMed ID: 17408393
[TBL] [Abstract][Full Text] [Related]
18. Etanercept, a TNF antagonist for treatment for psoriatic arthritis and psoriasis.
Mease PJ
Skin Therapy Lett; 2003 Jan; 8(1):1-4. PubMed ID: 12728284
[TBL] [Abstract][Full Text] [Related]
19. [Long-term safety and efficacy of etanercept in the treatment of psoriasis].
Zaragoza V; Pérez A; Sánchez JL; Oliver V; Martínez L; Alegre V
Actas Dermosifiliogr; 2010; 101(1):47-53. PubMed ID: 20109392
[TBL] [Abstract][Full Text] [Related]
20. Use of anti-tumor necrosis factor-α therapy in hepatitis B virus carriers with psoriasis or psoriatic arthritis: a case series in Taiwan.
Cho YT; Chen CH; Chiu HY; Tsai TF
J Dermatol; 2012 Mar; 39(3):269-73. PubMed ID: 22077677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
